All you need to know for round 2 of the CRISPR patent fight – STAT
STAT |
All you need to know for round 2 of the CRISPR patent fight
STAT The patent office ruled 1 in February 2017 that the Broad’s 2014 CRISPR patent on using CRISPR-Cas9 to edit genomes, based on discoveries 2 by Feng Zhang, did not “interfere” with a patent application by UC based on the work of UC Berkeley’s Jennifer … |
STAT |
All you need to know for round 2 of the CRISPR patent fight
STAT The patent office ruled 1 in February 2017 that the Broad’s 2014 CRISPR patent on using CRISPR-Cas9 to edit genomes, based on discoveries 2 by Feng Zhang, did not “interfere” with a patent application by UC based on the work of UC Berkeley’s Jennifer … |
PharmaTimes |
CAR–T therapy could be available to NHS patients this year
PharmaTimes NHS England chief executive Simon Stevens has indicated that chimeric antigen receptor T–cell therapy (CAR-T) could be available on the NHS this year, offering eligible patients a ‘ground-breaking’ approach to treating cancer. Addressing the … New CAR–T therapy could provide safer, more effective cancer treatmentNews-Medical.net Risk Versus Reward: The Value of Cell Therapy for Patients and InvestorsMENAFN.COM |
News-Medical.net |
New CAR–T therapy could provide safer, more effective cancer treatment
News-Medical.net There have been few cancer treatments with such a promising future as using the patient’s own immune system. Known as chimeric antigen receptor T–cell therapy, or CAR-T, this treatment uses re-engineered killer T–cells to attack cancer cells, but it … |